Schrier Derek C 的 Form 4 申報
Tabula Rasa HealthCare, Inc.TRHC,2023/11/14 申報
- 申報編號
- 0000921895-23-002642
- 申報時間
- 2023/11/14 18:00 ET
- 交易日
- 2023/11/3-11/7
- 申報延遲
- 11 天遲報
- 10b5-1 計畫
- 沒有勾選
這份申報列了 1 筆非衍生性交易、2 筆衍生性交易。交易後 11 天才申報,超過 2 個營業日的期限。
申報人
一份 Form 4 可以有好幾位申報人,例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Schrier Derek CCIK 0001250078 | 董事、持股 10% 以上大股東 |
| Indaba Capital Fund, L.P.CIK 0001516452 | 董事 |
| Indaba Capital Management, L.P.CIK 0001524362 | 董事、持股 10% 以上大股東 |
| Ic GP, LLCCIK 0001596505 | 董事、持股 10% 以上大股東 |
非衍生性證券(表 I)
普通股等股票的取得與處分,每一列是申報上的一筆。
衍生性證券(表 II)
選擇權、認股權證、限制型股票單位等。股數是標的股票的股數;單價與金額是衍生證券本身的價格,交易後持有是衍生證券的單位數。
| 交易日 | 證券 | 交易 | 標的股數 | 單價 | 金額 | 交易後持有 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2023/11/6 | Common Stock | S賣出處分 | −965,020 | $67,243,500.00 | −$4,538,936,250,000,000 | 317,785 | 間接 | 價格異常 |
| 2023/11/7 | Common Stock | S賣出處分 | −317,785 | $22,145,756.00 | −$492,255,864,368,000 | 0 | 間接 | 價格異常 |
附註與備註
本站收錄交易價格引用的附註、修正申報(Form 4/A)的全部附註,以及申報的備註。其他附註,例如間接持有的方式、交易計畫的細節,請看 SEC EDGAR 上的原文。
- F2
Pursuant to the Merger Agreement, at the effective time of the Merger (the "Effective Time"), each share of the Issuer's common stock ("Common Stock") issued and outstanding immediately prior to the Effective Time was cancelled and automatically converted into the right to receive an amount in cash equal to $10.50 per share, without interest (the "Merger Consideration").
表 I 有 1 筆交易的價格引用這則附註。
- F3
Pursuant to the Merger Agreement, at the Effective Time, each outstanding (i) (A) restricted stock unit that was subject solely to time-based vesting conditions (each, a "Company RSU"), whether vested or unvested, and (B) share of Common Stock that was subject to vesting, repurchase or forfeiture (each, a "Company Restricted Share"), and (ii) restricted stock unit that was subject to both performance-based and time-based vesting conditions (each, a "Company PSU") that was vested as of immediately prior to the Effective Time but not yet settled or that automatically vested as a result of the Merger in accordance with its terms and without the exercise of discretion (each, a "Vested Company PSU"), in the case of each of clause (i) and (ii), was canceled and the holder thereof became entitled to receive an amount in cash equal to the Merger Consideration, provided that any Company PSU that did not constitute a Vested Company PSU was forfeited and canceled for no consideration.
表 I 有 1 筆交易的價格引用這則附註。
備註
Derek C. Schrier, the Managing Member of IC GP, LLC, the general partner of the investment manager of Indaba Capital Fund, L.P., was a director of the Issuer. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the Reporting Persons were deemed directors by deputization by virtue of their representation on the Board of Directors of the Issuer.